Scrip
Novo Nordisk launches improved NovoSeven in India
06 November 2009
Anju Ghangurde
Please Login to read the full article.
06 November 2009
Anju Ghangurde
aghangurde@yahoo.com
Novo Nordisk has launched a new room temperature-stable formulation of its recombinant Factor VIIa product NovoSeven for haemophilia with inhibitors in India. The improved formulation will be available as 1mg and 2mg strengths that can be used intravenously to stop bleeding in inhibitor patients....
Please Login to read the full article.
RELATED CONTENT
NEWS
- Mergers and acquisitions repositioning multinationals at the helm in India
- Biosimilar EPO and novel antidiabetics lead raft of Japanese approvals
- R&D update: Sun upbeat on gabapentin pro-drug and extended-release baclofen
- Merck pipeline update: ESA development ditched because of regulatory hurdles
COMMENT
Other Informa Comment
FEATURES
- Anti-obesity drugs: an inventor's perspective
- Recipharm sees opportunity to ride wave of CDMO consolidation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
